Conference abstractPublished 7 Dec 2015
Plant- Made Biopharmaceuticals for Developing Countries
University of Toronto, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plant-produced vaccines offer enormous potential for providing relief to developing countries by reducing the incidence of infant mortality caused by infectious diseases. Vaccines derived from plants have been demonstrated to effectively elicit strong immune responses. These plant-made biopharmaceuticals are inexpensive to produce, require fewer purification steps, and can be stored at ambient temperatures for prolonged periods of time. As a result, plant-produced vaccines have the potential to be more accessible to the rural poor. This presentation will provide an overview of plant-produced biopharmaceuticals that are under development to target infectious diseases including human immunodeficiency virus, malaria and Ebola virus
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Kathleen Hefferon”
